Dr. Rosner serves as CEO of UVA Health and executive vice president for health affairs for the University of Virginia, bringing a longstanding record of clinical excellence, academic distinction and values-driven executive leadership to one of the most impactful academic health systems in the country. A board-certified nephrologist and nationally respected physician-scientist, he holds the Henry B. Mulholland Professorship of Medicine, has authored more than 200 peer-reviewed publications and seven books, serves as education director for the International Society of Nephrology, and is the recipient of the American Society of Nephrology’s “Robert Narins Award” for outstanding lifetime contributions to education. Prior to his current role, Dr. Rosner chaired the University of Virginia School of Medicine’s department of medicine, which is its largest clinical department. There, he oversaw the growth of major strategic programs in cardiology, oncology and critical care. In early 2025, he was called upon to serve as interim executive vice president for health affairs during a period of significant organizational disruption, and his transparent communication, consistent presence and empathetic engagement with UVA Health’s 18,000 team members built trust and led to his appointment as permanent executive vice president and CEO in September 2025. Dr. Rosner is still committed to clinical practice, maintaining weekly time in his nephrology clinic to ensure that strategic decisions remain grounded in the realities of frontline patient care. He was awarded the University of Virginia’s “Thomas Jefferson Award” in 2022, which is the highest honor bestowed upon a member of the UVA community. He was also elected fellow of the Royal Society of Physicians in 2023.
